• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

毒理学筛查中的确认与确定性。

Confirmation and certainty in toxicology screening.

作者信息

Spiehler V R, O'Donnell C M, Gokhale D V

机构信息

Diagnostic Products Corp., Los Angeles, CA.

出版信息

Clin Chem. 1988 Aug;34(8):1535-9.

PMID:3042189
Abstract

Confirmation of presumptive positive urine drug screens, necessary to minimize the reporting of false-positive results, can be costly and time-consuming. The predictive value model can be used to select the confirming tests and to calculate the confidence of the result. The predictive value of a test result is the probability, based on the sensitivity and specificity of the test, that the result is a true positive or a true negative. The predictive value model applied to toxicology screening tests for drugs of abuse showed that prevalence, in addition to sensitivity and specificity, was the factor controlling the confidence level of a result. For example, the predictive value of a positive result for a screening test that has a sensitivity of 99% and a specificity of 99%, applied to screening in a population with a prevalence of 1% is 0.50; for a prevalence of 10%, it is 0.92. Confirmation with a second, chemically independent, test of equal sensitivity and specificity increases the predictive value to 0.99.

摘要

为尽量减少假阳性结果的报告,对尿液药物筛查初步阳性结果进行确认可能既费钱又耗时。预测值模型可用于选择确认试验并计算结果的可信度。试验结果的预测值是基于试验的敏感性和特异性,该结果为真阳性或真阴性的概率。应用于药物滥用毒理学筛查试验的预测值模型表明,除敏感性和特异性外,患病率是控制结果置信水平的因素。例如,一项敏感性为99%、特异性为99%的筛查试验,应用于患病率为1%的人群进行筛查时,阳性结果的预测值为0.50;患病率为10%时,预测值为0.92。用第二项敏感性和特异性相同的化学独立试验进行确认,可将预测值提高到0.99。

相似文献

1
Confirmation and certainty in toxicology screening.毒理学筛查中的确认与确定性。
Clin Chem. 1988 Aug;34(8):1535-9.
2
Preemployment qualitative urine toxicology screening.就业前定性尿液毒理学筛查。
J Occup Med. 1983 Aug;25(8):579-80.
3
Potential risk of patient misclassification using a point-of-care testing kit for urine drugs of abuse.使用即时检验试剂盒检测尿液中滥用药物时患者误分类的潜在风险。
Br J Biomed Sci. 2010;67(4):218-20. doi: 10.1080/09674845.2010.11978228.
4
Utilization and yield of drug screening in the emergency department.急诊科药物筛查的应用与结果
Am J Emerg Med. 1988 Jan;6(1):14-20. doi: 10.1016/0735-6757(88)90197-0.
5
Performance of three point-of-care urinalysis test devices for drugs of abuse and therapeutic drugs applied in the emergency department.三种用于急诊部门滥用药物和治疗药物即时检验的尿液分析测试设备的性能
J Emerg Med. 2012 Jun;42(6):682-91. doi: 10.1016/j.jemermed.2011.01.031. Epub 2011 Sep 10.
6
Perinatal toxicology screening.围产期毒理学筛查
J Perinatol. 1992 Sep;12(3):220-4.
7
A High-throughput HPLC-MS/MS Assay for the Detection, Quantification and Simultaneous Structural Confirmation of 136 Drugs and Metabolites in Human Urine.一种用于检测、定量和同时进行结构确证人体尿液中136种药物及代谢物的高通量高效液相色谱-串联质谱分析法。
Ther Drug Monit. 2017 Oct;39(5):565-574. doi: 10.1097/FTD.0000000000000429.
8
[Substance abuse analysis of biological materials].[生物材料的药物滥用分析]
Tidsskr Nor Laegeforen. 1991 Nov 10;111(27):3300-3.
9
Improved cost effective thin-layer detection techniques for routine surveillance of commonly abused drugs in drug abuse urine screening and proficiency testing programs with built-in quality assurance.
J Chromatogr. 1983 Sep 2;267(1):109-16. doi: 10.1016/s0021-9673(01)90824-6.
10
A chart review of the ordering and documentation of urine toxicology screens in a cancer center: do they influence patient management?癌症中心尿液毒理学筛查的医嘱及记录的图表回顾:它们会影响患者管理吗?
J Pain Symptom Manage. 2000 Jan;19(1):40-4. doi: 10.1016/s0885-3924(99)00137-2.

引用本文的文献

1
Testing for benzodiazepine inebriation--relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers.苯二氮䓬类药物中毒检测——苯二氮䓬类药物浓度与一组吸毒驾车者样本中简单的损害临床测试之间的关系。
Eur J Clin Pharmacol. 2003 Nov;59(8-9):593-601. doi: 10.1007/s00228-003-0677-0. Epub 2003 Sep 20.
2
Drugs and brain death.药物与脑死亡
Drug Saf. 1996 Mar;14(3):171-80. doi: 10.2165/00002018-199614030-00004.
3
Testing for drugs of abuse. Pharmacokinetic considerations for cocaine in urine.
滥用药物检测。尿液中可卡因的药代动力学考量。
Clin Pharmacokinet. 1993 May;24(5):355-61. doi: 10.2165/00003088-199324050-00001.